<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03645720</url>
  </required_header>
  <id_info>
    <org_study_id>2018-05-030</org_study_id>
    <nct_id>NCT03645720</nct_id>
  </id_info>
  <brief_title>The Prognosis of Graft Using Plastic Cannula in Hemodialysis</brief_title>
  <official_title>A Prospective Study of the Prognosis of Graft With Plastic Cannula in Hemodialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hallym University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hallym University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the complication of the puncture related
      complication in AVG (arteriovenous graft) such as pseudoaneurysm and hematoma, and the
      dialysis adequacy using plastic cannula versus metal needle in hemodialysis patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Ultrasonography is performed to determine the maturity of vascular access 4 weeks after
           AVG creation.

        2. The first puncture is performed with plastic cannula or metal needle when it is judged
           that the blood vessel has matured.

        3. Four skilled nurses perform vascular access puncture with plastic or metal needle

        4. Ultrasound are used to evaluate and record the complications related to the puncture in
           plastic or metal needle group every month.

        5. Complications and dialysis adequacy between the two groups will be evaluated after 6
           months
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 22, 2018</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of pseudoaneurysm</measure>
    <time_frame>Incidence of pseudoaneurysm at 6 months</time_frame>
    <description>critical puncture related complication in AVG</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>punctutre related complication</measure>
    <time_frame>Monthly for 6 months.</time_frame>
    <description>hematoma, inflitration, thrombus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dialysis adeqaucy</measure>
    <time_frame>Monthly for 6 months.</time_frame>
    <description>Kt/V by serum test in two groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>End Stage Renal Failure on Dialysis</condition>
  <arm_group>
    <arm_group_label>Metal needle gruop</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>puncture using metal needle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>plastic cannula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>puncture using plastic cannula</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Plastic cannula</intervention_name>
    <description>puncture using plastic cannula</description>
    <arm_group_label>plastic cannula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients receiving hemodialysis treatment using AVG

        Exclusion Criteria:

          -  Age under 20 years old or over 75 years old

          -  Abnormal skin condition using immunosuppressants such as steroids.

          -  Skin disorder

          -  Metal allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sun Ryoung Choi, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hallym University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sun Ryoung Choi, MD,phD</last_name>
    <phone>+82-31-380-4739</phone>
    <phone_ext>4739</phone_ext>
    <email>ryounge@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hallym University Sacred Heart Hospital</name>
      <address>
        <city>Anyang si</city>
        <state>Gyeonggi-do</state>
        <zip>14066</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sun Ryoung Choi, MD,PhD</last_name>
      <phone>+82-31-380-4739</phone>
      <phone_ext>4739</phone_ext>
      <email>ryounge@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Hyung Seok Lee, MD</last_name>
      <phone>+82-31-380-4739</phone>
      <phone_ext>4739</phone_ext>
      <email>pcsacred@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>August 21, 2018</study_first_submitted>
  <study_first_submitted_qc>August 22, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 24, 2018</study_first_posted>
  <last_update_submitted>November 19, 2018</last_update_submitted>
  <last_update_submitted_qc>November 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hallym University Medical Center</investigator_affiliation>
    <investigator_full_name>choi sun ryoung, MD</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

